NL-OMON26696尚未招募不适用
A Randomized Controlled Phase II Clinical Trial with Intradermal IMO-2125 (Tilsotolimod) in clinical cT3-4N0M0 Melanoma
VU University medical center0 个研究点目标入组 214 人开始时间: 待定最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 214
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Patients must be willing and able to sign the informed consent and comply with the study protocol.
- •2.Must be ≥18 years of age.
排除标准
- •1.Known hypersensitivity to any oligodeoxynucleotide.
- •2.Active autoimmune disease requiring disease-modifying therapy at the time of screening.
研究者
相似试验
招募中
2 期
A Randomized Controlled Phase II Clinical Trial with Intradermal IMO-2125 (Tilsotolimod) in pT3-4 cN0M0 Melanomaskin cancerMelanomaNL-OMON52549Vrije Universiteit Medisch Centrum214
招募中
不适用
A Randomized Controlled Phase II Clinical Trial of Reconstruction method for the Elderly patients with gastric cancer after Distal Gastrectomy; Billroth-II Versus Roux-en-Y reconstructiogastric canerJPRN-UMIN000046950Clinical Study Group of Osaka University100
尚未招募
不适用
A short-term ketogenic diet combined with 24-hour fasting and chemoprotection for patients with acute myeloid leukaemiaacute myeloid leukemiaACTRN12620000850976epean Blue Mountains Local Health District134
招募中
1 期
A Phase 2, Double-Blind, Randomized Clinical Trial to Explore the Safety, Tolerability, Efficacy, and Pharmacokinetics of PRAX-562 in Pediatric Participants with Developmental and Epileptic Encephalopathies Followed by an Open-Label ExtensioCTIS2022-502298-41-00Praxis Precision Medicines Inc.20
进行中（未招募）
不适用
A Clinical Trial to Study the Safety and Effectiveness of MK-5172 with Ribavirin in Patients with Hepatitis CEUCTR2012-003340-72-ESMerck Sharp & Dohme Corp.24